Concepedia
Statistics
Publications
12
Citations
2.5K
H-Index
11
Active since
2003
Affiliations
United States Food and Drug Administration(Current)
University of Southern California
University of California, San Francisco
Harvard University
Duke University
Billy Dunn is an author at United States Food and Drug Administration specializing in neurology, medicine, and treatment.
Top concepts
MedicineNeurologyTreatmentAlzheimer's DiseaseNeurodegenerative DiseasesStrokeThrombosisNeurosciencePharmacologyPublic Health
Publications per year
2003–2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia · 2024 · 1.7K citations · Full text
Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective
Billy Dunn, Peter Stein, Patrizia Cavazzoni · JAMA Internal Medicine · 2021 · 233 citations
Neurodegenerative Diseases, Alzheimer's Disease, Website Uses Cookies +15
Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Jeffrey L. Saver, Gregory W. Albers, Billy Dunn et al. · Stroke · 2009 · 151 citations · Full text
Endovascular Technique, Cerebrovascular Disease, Neurological Rehabilitation +20
Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era
Julio A. Chalela, Dong‐Wha Kang, Marie Luby et al. · Annals of Neurology · 2003 · 131 citations
Landscape Analysis of the Application of Artificial Intelligence and Machine Learning in Regulatory Submissions for Drug Development From 2016 to 2021
Qi Liu, Ruihao Huang, Julie Hsieh et al. · Clinical Pharmacology & Therapeutics · 2022 · 76 citations · Full text
1–5 of 12